Acta Scientific Cancer Biology (ASCB) (ISSN: 2582-4473)

Editorial Volume 7 Issue 8

Ostensible and Wiry-Superficial CD34+ Fibroblastic Tumour

Anubha Bajaj*

Department of Histopathology, Panjab University/A.B. Diagnostics, India

*Corresponding Author: Anubha Bajaj, Department of Histopathology, Panjab University/A.B. Diagnostics, India.

Received: August 02, 2023; Published: September 01, 2023

Superficial CD34+ fibroblastic tumour is a distinctive, low grade tumefaction arising within superficial sites as diverse cutaneous surfaces or subcutaneous tissue. Superficial CD34+ fibroblastic tumour is additionally designated as PRDM10 rearranged soft tissue tumour. Characteristically, fascicular proliferation of spindle shaped cells pervaded with abundant, eosinophilic, granular to glassy cytoplasm is encountered. Although nuclear pleomorphism may be significant, mitotic activity is minimal. Tumour cells comprehensively appear immune reactive to CD34. Besides, focal immune reactivity to keratin (AE1/AE3) is encountered within ~ 70% neoplasms.

References

  1. Sugita S., et al. “Usefulness of SynCAM3 and cyclin D1 immunohistochemistry in distinguishing superficial CD34-positive fibroblastic tumor from its histological mimics”. Medical Molecular Morphology 1 (2023): 69-77.
  2. Salah HT., et al. “Superficial CD34-positive fibroblastic tumor (SCPFT): A review of pathological and clinical features”. Annals of Diagnostic Pathology 58 (2022): 151937.
  3. Anderson WJ., et al. “Superficial CD34-Positive Fibroblastic Tumor: A Clinicopathologic, Immunohistochemical, and Molecular Study of 59 Cases”. The American Journal of Surgical Pathology 10 (2022): 1329-1339. 
  4. Bruce-Brand C., et al. “Superficial CD34 Positive Fibroblastic Tumour with Myxoid Stroma”. International Journal of Surgical Pathology 11 (2022): 10668969221126109.
  5. Salah HT., et al. “Case of recurrent superficial CD34-positive fibroblastic tumor”. Journal of Cutaneous Pathology (2022).
  6. Image 1 Courtesy: Wiley online library.
  7. Image 2 Courtesy: Nature.com.

Citation

Citation: Anubha Bajaj. “Ostensible and Wiry-Superficial CD34+ Fibroblastic Tumour." Acta Scientific Cancer Biology 7.8 (2023): 01-03.

Copyright

Copyright: © 2023 Anubha Bajaj. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US